Navigation Links
Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
Date:6/12/2008

ER920W Showcased at HRS Conference

MINNEAPOLIS, June 12 /PRNewswire-FirstCall/ -- Braemar, Inc., a subsidiary of Biotel, Inc. (OTC Bulletin Board: BTEL) and a world leader in ambulatory cardiac monitoring devices, has introduced the ER920W, an advanced wireless device that integrates cardiac arrhythmia monitoring and cell phone technologies in one unit. The ER920W is a digital loop recorder with on-board arrhythmia detection algorithms for automatic detection, recording and immediate transmission of patient data files to a service center for analysis and physician attention. Transmission occurs without patient interaction and without connection through a separate cell phone, reducing potential anomalies in the prescribed testing routine and avoiding the possibility of the patient forgetting to carry the cell phone. The device, which has FDA 510(k) clearance, was showcased at the recent Heart Rhythm Society (HRS) conference in San Francisco.

The ER920W connects the patient to a 24/7 monitoring center. Its telecommunications architecture, including cellular network, Internet and Braemar's proprietary LINX Management software interface, allows for bidirectional data flow, so the physician can monitor the patient's cardiac events and remotely program the device as required. The cellular transmitter embedded in the ER920W uses a "Quad-Band" modem for maximum flexibility and is compatible with both GSM and GPRS cellular networks.

"The ER920W is an advanced arrhythmia monitor with proprietary technology that we believe represents the next generation of cardiac event monitoring," Harry Strandquist, President of Braemar, Inc. said. "The ER920W provides faster patient diagnosis, improves patient compliance and is far superior to the current cumbersome transmission method. This device is the first in a series of Braemar wireless arrhythmia monitoring products currently under development."

Cardiac arrhythmia monitors are worn by patients for up to 30 days to document and record transient cardiac events. Recording of symptomatic events such as syncope, palpitations, dizziness, chest discomfort and shortness of breath is activated by the patient. The ER920W enhances diagnostic yield with embedded algorithms that automatically detect, record and immediately transmit asymptomatic events such as atrial fibrillation, bradycardia, tachycardia and cardiac pause.

A photo of the ER920W is available at http://www.biotelinc.com/images/BraemarER920W.jpg.

Braemar, Inc., designs, develops, engineers and manufactures ambulatory cardiac monitoring and other medical devices. The company provides high-quality, reliable devices to OEM partners worldwide.


'/>"/>
SOURCE Braemar, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
5. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
6. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... NEW YORK , Feb. 20, 2017  This Report analyzes ... Software, Hardware, and Biocontent. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific , ... Read the full report: http://www.reportlinker.com/p04707099-summary/view-report.html ... Annual estimates and forecasts ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... success among radiotherapy patients, prevent chest wall collapses in pre-term infants with ... will receive a total of $600,000 in funding through the ninth round ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... OHAUS Corporation ventured outside of weighing equipment with the goal of expanding the ... in mind, the line of Starter water analysis meters were introduced into the ...
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/21/2017)... 20, 2017 Research and Markets has announced ... report to their offering. ... The global voice recognition biometrics market to grow ... The report covers the present scenario and the growth prospects ... the market size, the report considers the revenue generated from the ...
(Date:1/13/2017)... WASHINGTON, N.Y. , Jan. 13, 2017 /PRNewswire/ ... of technology solutions for the homecare industry, including ... of homecare industry expert, Justin Jugs, as Senior ... brings more than 15 years of homecare experience ... team in developing strategic plans to align Sandata,s ...
Breaking Biology News(10 mins):